Home › Funds › 5AM Venture Management, LLC › CLDX
5AM Venture Management, LLC position in CLDX
CELLDEX THERAPEUTICS INC NEW · Health Care
5AM Venture Management, LLC reported holding 497,270 shares of CLDX (CELLDEX THERAPEUTICS INC NEW) in its Q2 2026 13F filing — a position valued at US$18.5M, representing 6.43% of its reported portfolio and ranking #9 among its reported holdings. 5AM Venture Management, LLC has disclosed CLDX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How 5AM Venture Management, LLC's CLDX position evolved
5AM Venture Management, LLC first disclosed a stake in CLDX in Q3 2023 at 310,270 shares (US$8.5M). The position peaked in Q1 2024 at 497,270 shares, worth US$20.9M. Across 12 filings, 5AM Venture Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 10 time(s). The most recent filing (Q2 2026) shows 497,270 shares valued at US$18.5M. Notable position changes include a 60% increase in Q4 2023 (shares rose 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 310.27K | $8.54M | New |
| Q4 2023 | 497.27K | $19.72M | Add |
| Q1 2024 | 497.27K | $20.87M | Hold |
| Q2 2024 | 497.27K | $18.40M | Hold |
| Q3 2024 | 497.27K | $16.90M | Hold |
| Q4 2024 | 497.27K | $12.57M | Hold |
| Q1 2025 | 497.27K | $9.03M | Hold |
| Q2 2025 | 497.27K | $10.12M | Hold |
| Q3 2025 | 497.27K | $12.86M | Hold |
| Q4 2025 | 497.27K | $13.51M | Hold |
| Q1 2026 | 497.27K | $15.77M | Hold |
| Q2 2026 | 497.27K | $18.50M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CLDX and 13F data
CLDX (CELLDEX THERAPEUTICS INC NEW) is a Health Care company. 44 other funds we track also report a position in CLDX — the largest reported positions include Kynam Capital Management, LP (US$198.1M), Deep Track Capital, LP (US$109.4M), Logos Global Management LP (US$78.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CLDX
- Kynam Capital Management, LP 5.32M sh · $198.07M · Q2 2026
- Deep Track Capital, LP 2.94M sh · $109.37M · Q2 2026
- Logos Global Management LP 2.10M sh · $78.14M · Q2 2026
- Eversept Partners, LP 1.79M sh · $66.45M · Q2 2026
- Commodore Capital LP 1.35M sh · $50.23M · Q2 2026
- Bellevue Group AG 1.20M sh · $44.65M · Q2 2026
- BAKER BROS. ADVISORS LP 1.18M sh · $44.00M · Q2 2026
- Novo Holdings A/S 1.02M sh · $38.14M · Q2 2026
- Elmind Capital, LP 990.00K sh · $36.84M · Q2 2026
- Foresite Capital Management VI LLC 879.71K sh · $32.73M · Q2 2026
- Affinity Asset Advisors, LLC 700.00K sh · $26.05M · Q2 2026
- Rock Springs Capital Management LP 699.15K sh · $26.02M · Q2 2026
More on 5AM Venture Management, LLC
FAQ
How long has 5AM Venture Management, LLC held CLDX?
5AM Venture Management, LLC has disclosed CLDX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is 5AM Venture Management, LLC's current position in CLDX?
As of Q2 2026, 5AM Venture Management, LLC holds 497.27K shares of CLDX (CELLDEX THERAPEUTICS INC NEW), valued at $18.50M, representing 6.43% of its reported portfolio and ranking #9.
Has 5AM Venture Management, LLC been buying or selling CLDX?
In the latest 13F filing (Q2 2026), 5AM Venture Management, LLC held unchanged its position in CLDX. The position peaked in Q1 2024 at 497.27K shares.
Which other funds hold CLDX?
Other major institutional holders of CLDX include Kynam Capital Management, LP, Deep Track Capital, LP, Logos Global Management LP, among 44 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.